Lukas Burghart

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 17

Top Topics

Atrial Fibrillation

Mesenchymal Stem Cells

Top Venues

Alimentary pharmacology & therapeutics

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Lukas Burghart, Peter Ferenci, Oleksandr Petrenko, Mattias Mandorfer, Michael Schwarz, Michael Gschwantler, Michael Trauner, Thomas Reiberger, Albert Friedrich Stättermayer
Portal hypertension and its prognostic implications in patients with Wilson's disease. Alimentary pharmacology & therapeutics 60 (2) (2024)
Lukas Burghart, Benedikt Silvester Hofer, Emina Halilbasic, Benedikt Simbrunner, Albert Friedrich Staettermayer, Michael Trauner, Thomas Reiberger
Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply. Alimentary pharmacology & therapeutics 60 (1) (2024)
Benedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger
Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply. Alimentary pharmacology & therapeutics 59 (9) (2024)
Benedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Alimentary pharmacology & therapeutics 59 (8) (2024)
Georg Semmler, Sonia Alonso López, Mónica Pons, Sabela Lens, Elton Dajti, Marie Griemsmann, Alberto Zanetto, Lukas Burghart, Stefanie Hametner-Schreil, Lukas Hartl, Marisa Manzano, Sergio Rodriguez-Tajes, Paola Zanaga, Michael Schwarz, María L Gutierrez, Mathias Jachs, Anna Pocurull, Benjamín Polo, Dominik Ecker, Beatriz Mateos, Sonia Izquierdo, Yolanda Real, Lorenz Balcar, Juan Antonio Carbonell-Asins, Michael Gschwantler, Francesco Paolo Russo, Francesco Azzaroli, Benjamin Maasoumy, Thomas Reiberger, Xavier Forns, Joan Genescà, Rafael Bañares, Mattias Mandorfer
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure. Hepatology (Baltimore, Md.) (2024)
Lukas Burghart, Peter Ferenci, Oleksandr Petrenko, Mattias Mandorfer, Michael Schwarz, Michael Gschwantler, Michael Trauner, Thomas Reiberger, Albert Friedrich Stättermayer
Portal hypertension and its prognostic implications in patients with Wilson's disease. Alimentary pharmacology & therapeutics 60 (2) (2024)
Benedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Alimentary pharmacology & therapeutics (2024)
Benedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger
Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply. Alimentary pharmacology & therapeutics 59 (9) (2024)
Lukas Burghart, Benedikt Silvester Hofer, Emina Halilbasic, Benedikt Simbrunner, Albert Friedrich Staettermayer, Michael Trauner, Thomas Reiberger
Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply. Alimentary pharmacology & therapeutics 60 (1) (2024)
Benedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Alimentary pharmacology & therapeutics 59 (8) (2024)
Lukas Burghart, Thomas Reiberger, Albert Friedrich Staettermayer
Editorial: Tracking the course of Wilson's disease: Authors' reply. Alimentary pharmacology & therapeutics (2024)
Lukas Burghart, Thomas Reiberger, Albert Friedrich Staettermayer
Editorial: Tracking the course of Wilson's disease: Authors' reply. Alimentary pharmacology & therapeutics 60 (6) (2024)
Benedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Alimentary pharmacology & therapeutics 59 (8) (2024)
Lukas Burghart, Benedikt Silvester Hofer, Emina Halilbasic, Benedikt Simbrunner, Albert Friedrich Staettermayer, Michael Trauner, Thomas Reiberger
Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis-Authors' reply. Alimentary pharmacology & therapeutics (2024)
Benedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, Benedikt Simbrunner, Oleksandr Petrenko, Mattias Mandorfer, Albert Friedrich Stättermayer, Michael Trauner, Thomas Reiberger
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Alimentary pharmacology & therapeutics 59 (8) (2024)
Lukas Burghart, Peter Ferenci, Oleksandr Petrenko, Mattias Mandorfer, Michael Schwarz, Michael Gschwantler, Michael Trauner, Thomas Reiberger, Albert Friedrich Stättermayer
Portal hypertension and its prognostic implications in patients with Wilson's disease. Alimentary pharmacology & therapeutics (2024)
Lukas Burghart, Thomas Reiberger, Albert Friedrich Staettermayer
Editorial: Tracking the course of Wilson's disease: Authors' reply. Alimentary pharmacology & therapeutics 60 (6) (2024)